tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Capricor Therapeutics price target raised to $13 from $12 at Roth Capital
PremiumThe FlyCapricor Therapeutics price target raised to $13 from $12 at Roth Capital
18d ago
Optimistic Outlook for Capricor Therapeutics Amid Upcoming HOPE-3 Trial Data and Potential FDA Flexibility
Premium
Ratings
Optimistic Outlook for Capricor Therapeutics Amid Upcoming HOPE-3 Trial Data and Potential FDA Flexibility
18d ago
Capricor Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Capricor Therapeutics Reports Q3 2025 Financial Results
18d ago
Capricor Therapeutics management to meet with Piper Sandler
PremiumThe FlyCapricor Therapeutics management to meet with Piper Sandler
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Capricor approval on track for mid-2026, says JonesResearch
PremiumThe FlyCapricor approval on track for mid-2026, says JonesResearch
2M ago
Unusually active option classes on open September 25th
Premium
The Fly
Unusually active option classes on open September 25th
2M ago
Capricor to submit HOPE-3 data with complete response to FDA CRL
Premium
The Fly
Capricor to submit HOPE-3 data with complete response to FDA CRL
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100